These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35079437)

  • 1. Objective Quantitation of EGFR Protein Levels using Quantitative Dot Blot Method for the Prognosis of Gastric Cancer Patients.
    Xin L; Tang F; Song B; Yang M; Zhang J
    J Gastric Cancer; 2021 Dec; 21(4):335-351. PubMed ID: 35079437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Prognosis of Surrogate Assay for Breast Cancer Patients by Absolute Quantitation of Ki67 Protein Levels Using Quantitative Dot Blot (QDB) Method.
    Hao J; Lyu Y; Zou J; Zhang Y; Xie S; Jing L; Tang F; Lyu J; Zhang W; Zhang J; Wang X; Chen K; Zhang J
    Front Oncol; 2021; 11():737781. PubMed ID: 34604077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of absolutely quantitated Ki67 and cyclinD1 protein levels for prognosis of Luminal-like breast cancer patients.
    Yu G; Lyu J; Li Y; Zhang Y; Lyu Y; Zhang W; Zhang J; Cai B; Zhang J; Tang F
    J Clin Lab Anal; 2022 Aug; 36(8):e24601. PubMed ID: 35819123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients.
    Hao J; Zhang W; Lyu Y; Zou J; Zhang Y; Lyu J; Zhang J; Xie S; Zhang C; Zhang J; Tang F
    Front Oncol; 2021; 11():737794. PubMed ID: 34858818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
    Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
    Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.
    Petrini I; Lencioni M; Vasile E; Fornaro L; Belluomini L; Pasquini G; Ginocchi L; Caparello C; Musettini G; Vivaldi C; Caponi S; Ricci S; Proietti A; Fontanini G; Naccarato AG; Nardini V; Santi S; Falcone A
    Cancer Biomark; 2018 Feb; 21(3):731-741. PubMed ID: 29278885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a routine lab test for absolute quantification of HER2 in FFPE breast cancer tissues using Quantitative Dot Blot (QDB) method.
    Yu G; Zhang W; Zhang Y; Lv J; Wu S; Sui X; Zhang J; Tang F
    Sci Rep; 2020 Jul; 10(1):12502. PubMed ID: 32719400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Dot Blot (QDB) as a universal platform for absolute quantification of tissue biomarkers.
    Zhang W; Yu G; Zhang Y; Tang F; Lv J; Tian G; Zhang Y; Liu J; Mi J; Zhang J
    Anal Biochem; 2019 Jul; 576():42-47. PubMed ID: 30974091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantum dot-based quantitative immunofluorescence detection and spectrum analysis of epidermal growth factor receptor in breast cancer tissue arrays.
    Yang XQ; Chen C; Peng CW; Hou JX; Liu SP; Qi CB; Gong YP; Zhu XB; Pang DW; Li Y
    Int J Nanomedicine; 2011; 6():2265-73. PubMed ID: 22072864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELISA-like QDB method to meet the emerging need of Her2 assessment for breast cancer patients.
    Yu G; Lyu Y; Jiang L; Wang Y; Yin Y; Zhang J; Yang M; Tang F
    Front Oncol; 2023; 13():920698. PubMed ID: 36969021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue.
    Hembrough T; Thyparambil S; Liao WL; Darfler MM; Abdo J; Bengali KM; Taylor P; Tong J; Lara-Guerra H; Waddell TK; Moran MF; Tsao MS; Krizman DB; Burrows J
    Clin Proteomics; 2012 May; 9(1):5. PubMed ID: 22554165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II-IIIA (8th edition TNM classification) primary lung cancer after curative surgery.
    Isaka T; Ito H; Nakayama H; Yokose T; Saito H; Adachi H; Miura J; Shigefuku S; Kikuchi A; Rino Y
    Lung Cancer; 2021 Dec; 162():128-134. PubMed ID: 34775216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy.
    Su NW; Leu YS; Lee JC; Liu CJ; Cheng CY; Lin JS; Chen YJ; Chen CK; Fang IC; Hsieh RK; Chang YF
    Onco Targets Ther; 2014; 7():2197-204. PubMed ID: 25506224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancer.
    Wang P; Shi Q; Deng WH; Yu J; Zuo T; Mei FC; Wang WX
    World J Gastroenterol; 2015 May; 21(20):6271-9. PubMed ID: 26034362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
    Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
    Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Body Mass Index Is an Independent Prognostic Factor in Patients With Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.
    Minami S; Ihara S; Nishimatsu K; Komuta K
    World J Oncol; 2019 Dec; 10(6):187-198. PubMed ID: 31921375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.
    Terashima M; Kitada K; Ochiai A; Ichikawa W; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M;
    Clin Cancer Res; 2012 Nov; 18(21):5992-6000. PubMed ID: 22977193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas.
    Paliga A; Marginean H; Tessier-Cloutier B; Purgina B; Jonker D; Marginean EC
    Am J Clin Oncol; 2017 Dec; 40(6):543-551. PubMed ID: 26125303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer.
    Atmaca A; Werner D; Pauligk C; Steinmetz K; Wirtz R; Altmannsberger HM; Jäger E; Al-Batran SE
    BMC Cancer; 2012 Nov; 12():524. PubMed ID: 23153332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance.
    Jia W; Wang W; Ji CS; Niu JY; Lv YJ; Zhou HC; Hu B
    Onco Targets Ther; 2016; 9():5133-42. PubMed ID: 27574454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.